AliveDx Suisse S.A. (“AliveDx”), a global innovator in in-vitro diagnostics, and African Biotechnology Society (ABS), a leading Tunisian diagnostics and life sciences company, have signed a distribution agreement enabling ABS to distribute the MosaiQ® and LumiQ® solutions in Tunisia. The agreement is effective immediately. This partnership reinforces AliveDx’s commitment to expanding access to innovative diagnostic technologies and delivering both clinical and economic value to…